Lexicon Pharmaceuticals Inc (LXRX)
1.63
+0.01
(+0.62%)
USD |
NASDAQ |
Apr 18, 16:00
1.63
0.00 (0.00%)
After-Hours: 20:00
Lexicon Pharmaceuticals Free Cash Flow (Quarterly): -50.55M for Dec. 31, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -50.55M |
| September 30, 2023 | -41.70M |
| June 30, 2023 | -38.26M |
| March 31, 2023 | -31.86M |
| December 31, 2022 | -22.82M |
| September 30, 2022 | -19.44M |
| June 30, 2022 | -24.42M |
| March 31, 2022 | -23.50M |
| December 31, 2021 | -22.85M |
| September 30, 2021 | -17.36M |
| June 30, 2021 | -22.83M |
| March 31, 2021 | -25.20M |
| December 31, 2020 | -34.29M |
| September 30, 2020 | -40.41M |
| June 30, 2020 | -46.30M |
| March 31, 2020 | -22.05M |
| December 31, 2019 | -24.37M |
| September 30, 2019 | 190.70M |
| June 30, 2019 | -26.90M |
| March 31, 2019 | -25.69M |
| December 31, 2018 | -27.16M |
| September 30, 2018 | -22.18M |
| June 30, 2018 | -52.54M |
| March 31, 2018 | -46.82M |
| December 31, 2017 | -33.72M |
| Date | Value |
|---|---|
| September 30, 2017 | -34.02M |
| June 30, 2017 | -32.30M |
| March 31, 2017 | -85.59M |
| December 31, 2016 | -48.94M |
| September 30, 2016 | -35.24M |
| June 30, 2016 | -47.89M |
| March 31, 2016 | -43.79M |
| December 31, 2015 | 265.68M |
| September 30, 2015 | -25.67M |
| June 30, 2015 | -32.64M |
| March 31, 2015 | -23.50M |
| December 31, 2014 | -4.492M |
| September 30, 2014 | -21.20M |
| June 30, 2014 | -19.67M |
| March 31, 2014 | -30.35M |
| December 31, 2013 | -21.96M |
| September 30, 2013 | -24.20M |
| June 30, 2013 | -21.53M |
| March 31, 2013 | -25.11M |
| December 31, 2012 | -20.54M |
| September 30, 2012 | -25.12M |
| June 30, 2012 | -22.05M |
| March 31, 2012 | -27.24M |
| December 31, 2011 | -22.70M |
| September 30, 2011 | -20.40M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-50.55M
Minimum
Dec 2023
190.70M
Maximum
Sep 2019
-18.13M
Average
-24.42M
Median
Jun 2022
Free Cash Flow (Quarterly) Benchmarks
| Novavax Inc | -185.86M |
| AIM ImmunoTech Inc | -9.956M |
| Perspective Therapeutics Inc | -9.097M |
| Protalix BioTherapeutics Inc | 3.345M |
| Armata Pharmaceuticals Inc | -10.51M |